Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

References

• McGuireWPRowinskyEKRosensheinNBTaxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasmsAnn Intern Med19891112732792569287
   PubMed Web of Science ®Google Scholar
• HolmesFAWaltersRSTheriaultRLPhase II trial of taxol, an active drug in the treatment of metastatic breast cancerJ Natl Cancer Inst199183179718051683908
   PubMed Web of Science ®Google Scholar
• GeorgiadisMSRussellEKGazdarAFJohnsonBEPaclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durationsClin Cancer Res199734494549815704
   PubMed Web of Science ®Google Scholar
• PatelNSalifuMSumraniNSuccessful treatment of post-renal transplant Kaposi’s sarcoma with paclitaxelAm J Transplant2002287787912392295
   PubMed Web of Science ®Google Scholar
• ZhangZMeiLFengSSPaclitaxel drug delivery systemsExpert Opin Drug Deliv20131032534023289542
   PubMed Web of Science ®Google Scholar
• GallettiEMagnaniMRenzulliMLBottaMPaclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanesChemMedChem2007292094217530726
   PubMed Web of Science ®Google Scholar
• LiuLYangMKangRDAMP-mediated autophagy contributes to drug resistanceAutophagy2011711211421068541
   PubMed Web of Science ®Google Scholar
• WilliamsAJahreissLSarkarSAggregate – prone proteins are cleared from the cytosol by autophagy: therapeutic implicationsCurr Top Dev Biol2006768910117118264
   PubMed Web of Science ®Google Scholar
• ChenSRehmanSKZhangWWenAYaoLZhangJAutophagy is a therapeutic target in anticancer drug resistanceBiochim Biophys Acta2010180622022920637264
   PubMed Web of Science ®Google Scholar
• CarewJSNawrockiSTKahueCNTargeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistanceBlood200711031332217363733
   PubMed Web of Science ®Google Scholar
• ApelAHerrISchwarzHRodemannHPMayerABlocked autophagy sensitizes resistant carcinoma cells to radiation therapyCancer Res2008681485149418316613
   PubMed Web of Science ®Google Scholar
• AjabnoorGCrookTColeyHMPaclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cellsCell Death Dis20123e26022278287
   PubMed Web of Science ®Google Scholar
• WellemsTEPloweCVChloroquine-resistant malariaJ Infect Dis200118477077611517439
   PubMed Web of Science ®Google Scholar
• VerschootenLBarretteKVan KelstSAutophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cellsJ Clin Invest20127e48264
   Google Scholar
• WuDMaSSuiFZhangCYinLLuHReversal of CQ11, a chloroquine derivative, on multidrug resistance in doxorubicin-resistant breast cancer cell line MCF/DOXThe Chinese-German Journal of Clinical Oncology20087647649
   Google Scholar
• ZuckerDBarenholzYOptimization of vincristine-topotecan combination – paving the way for improved chemotherapy regimens by nanoliposomesJ Control Release201014632633320685223
   PubMed Web of Science ®Google Scholar
• ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl – 2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsSmall200952673267719780069
   PubMed Web of Science ®Google Scholar
• YangTCuiFDChoiMKEnhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluationInt J Pharm200733831732617368984
   PubMed Web of Science ®Google Scholar
• DoganALLegrandOFaussatAMPerrotJYMarieJPEvaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell linesLeuk Res20042861962215120939
   PubMed Web of Science ®Google Scholar
• MeszarosPKlappeKvan DamALong term myriocin treatment increases MRP1 transport activityInt J Biochem Cell Biol20134532633423178537
   PubMed Web of Science ®Google Scholar
• QiuLJingNJinYPreparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient methodInt J Pharm2008361566318573626
   PubMed Web of Science ®Google Scholar
• FritzeAHensFKimpflerASchubertRPeschka-SüssRRemote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradientBiochim Biophys Acta200617581633164016887094
   PubMed Web of Science ®Google Scholar
• JiXGaoYChenLZhangZDengYLiYNanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistanceInt J Pharm201242239039722001531
   PubMed Web of Science ®Google Scholar
• XiaoLXiongXSunXRole of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micellesBiomaterials2011325148515721546083
   PubMed Web of Science ®Google Scholar
• GelderblomHVerweijJNooterKSparreboomACremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer2001371590159811527683
   PubMed Web of Science ®Google Scholar
• ZahediPDe SouzaRHuynhLPiquette-MillerMAllenCCombination drug delivery strategy for the treatment of multidrug resistant ovarian cancerMol Pharm2010826026921166459
   PubMed Web of Science ®Google Scholar
• SharmaRSharmaAMultidrug resistance (MDR) in lung cancer: finding the holy grail of MDR reversalJ Cancer Sci Ther2012S11e001
   Google Scholar
• RenesJde VriesEGNienhuisEFJansenPLMüllerMATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1Br J Pharmacol199912668168810188979
   PubMed Web of Science ®Google Scholar
• VezmarMGeorgesEDirect binding of chloroquine to the multidrug resistance protein (MRP): possible role for MRP in chloroquine drug transport and resistance in tumor cellsBiochem Pharmacol1998567337429751078
   PubMed Web of Science ®Google Scholar
• OrreniusSKaminskyyVOZhivotovskyBAutophagy in toxicology: cause or consequence?Annu Rev Pharmacol Toxicol20135327529723072380
   PubMed Web of Science ®Google Scholar
• BellodiCLidonniciM RHamiltonATargeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cellsJ Clin Invest20095110919363292
   PubMedGoogle Scholar
• KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release20017219120211389998
   PubMed Web of Science ®Google Scholar
• EisemanJLEddingtonNDLeslieJPlasma pharmacokinetics and tissue distribution of placlitaxel in CD2F1 miceCancer Chemother Pharmacol1994344654717923556
   PubMed Web of Science ®Google Scholar
• VerbeeckRKJungingerHEMidhaKKShahVPBarendsDMBiowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochlorideJ Pharm Sci2005941389139515920763
   PubMed Web of Science ®Google Scholar
• MaiuriMCZalckvarEKimchiAKroemerGSelf-eating and self-killing: crosstalk between autophagy and apoptosisNat Rev Mol Cell Biol2007874175217717517
   PubMed Web of Science ®Google Scholar
• SolomonVRLeeHChloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapiesEur J Pharmacol200962522023319836374
   PubMed Web of Science ®Google Scholar
• ChaabaneWUserSDEl-GazzahMAutophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancerArch Immunol Ther Exp (Warsz)201361435823229678
   PubMed Web of Science ®Google Scholar